6.5 The Bishop Score & Cervical Ripening Methods

Pre-Induction Cervical Assessment: The Bishop Score

The Bishop score is a standardized clinical scoring tool used to predict the likelihood of successful vaginal delivery following induction. An unfavorable cervix is associated with prolonged latent phases, higher rates of failed induction, and increased cesarean birth.

The Standardized Bishop Scoring System

Clinical Interpretation & Decision-Making

• Bishop Score ≥ 8: Indicates a "ripe" or favorable cervix. The probability of achieving a successful vaginal birth with oxytocin induction alone is comparable to that of spontaneous labor onset. Cervical ripening agents are not required.
• Bishop Score < 6: Indicates an "unripe" or unfavorable cervix. Attempting direct oxytocin induction without prior cervical ripening results in high failure rates and increased cesarean deliveries. Pre-induction cervical ripening is clinically indicated.
• Bishop Score 6–7: Intermediate. The clinician may consider ripening or direct oxytocin depending on parity, membranes status, and clinical urgency.

---

Mechanical Methods of Cervical Ripening

Mechanical ripening methods act by directly dilating the endocervical canal and causing mechanical separation (stripping) of the amnion and chorion from the lower uterine segment, which stimulates local decidual release of endogenous prostaglandin F2α (PGF2α) and prostaglandin E2 (PGE2). Mechanical stretching also activates the neuroendocrine Ferguson reflex, stimulating neurohypophyseal oxytocin release.

Transcervical Foley Bulb Catheter

• Technique: A 16-Fr to 18-Fr Foley urinary catheter with a 30-mL balloon is inserted through the internal cervical os under direct visualization (speculum) or digitally. Once past the internal os, the balloon is inflated with 30 to 60 mL of sterile water or normal saline. The catheter is then taped to the inner aspect of the maternal thigh with gentle tension. Alternatively, a double-balloon catheter (Cook cervical ripening balloon) can be used, with 80 mL instilled into both the uterine and vaginal balloons.
• Clinical Trajectory: The catheter remains in place until it spontaneously expels (which signifies that the cervix has dilated to approximately 3 cm, usually within 6 to 12 hours) or for a maximum of 12 to 24 hours.
• Safety & TOLAC Profile: Unlike pharmacologic agents, mechanical catheters carry a negligible risk of uterine tachysystole or hyperstimulation with associated fetal heart rate decelerations. Consequently, the transcervical Foley bulb is the preferred first-line ripening method for Trial of Labor After Cesarean (TOLAC) / Vaginal Birth After Cesarean (VBAC).
• Contraindications: Low-lying placenta, unexplained vaginal bleeding, ruptured membranes with active intraamniotic infection, or cervical anatomical abnormalities.

Hygroscopic Dilators

• Laminaria digitata (dried seaweed stems) or synthetic hydrophilic polymers (Dilapan-S). They absorb endocervical moisture, expanding radially to slowly dilate the cervix. Primarily utilized in second-trimester terminations or late fetal demise, and less commonly in modern term labor induction.

---

Pharmacologic Cervical Ripening Agents

Exogenous prostaglandins act on cervical connective tissue by dissolving collagen fibrils, altering glycosaminoglycan composition, increasing submucosal water content, and relaxing cervical smooth muscle, while simultaneously stimulating myometrial contractility.

Prostaglandin E1: Misoprostol (Cytotec)

Misoprostol is a synthetic methyl ester analogue of prostaglandin E1. It is inexpensive, stable at ambient room temperature, and possesses rapid systemic absorption.

• Intravaginal Dosing: 25 mcg (one-fourth of a 100-mcg tablet) placed in the posterior vaginal fornix every 3 to 6 hours. Doses should not exceed 25 mcg per administration; higher doses (e.g., 50 mcg) significantly increase the risk of uterine tachysystole without accelerating delivery time.
• Oral Dosing: 25 to 50 mcg orally every 2 to 4 hours, or a titrated oral solution (20 to 25 mcg dissolved in water given every 2 hours). Oral administration produces fewer episodes of tachysystole with fetal heart rate decelerations than vaginal administration.
• Oxytocin Timing: Oxytocin administration must be delayed for at least 4 hours following the last dose of misoprostol to prevent synergistic myometrial hyperstimulation.
• CRITICAL BLACK-BOX CONTRAINDICATION: Misoprostol is ABSOLUTELY CONTRAINDICATED in patients with a prior cesarean delivery or prior transmural uterine surgery (e.g., full-thickness myomectomy). Its potent uterotonic effect carries an unacceptably high rate of catastrophic uterine rupture (5% to 10%+) in the scarred uterus.

Prostaglandin E2: Dinoprostone

Dinoprostone is a naturally occurring prostaglandin E2 formulation.

• Vaginal Insert (Cervidil): A 10-mg dinoprostone reservoir contained within a knitted polyester retrieval system. It releases drug at a controlled rate of approximately 0.3 mg per hour over 12 hours. It is placed transversely in the posterior vaginal fornix.
  • Clinical Advantage: If uterine tachysystole or non-reassuring fetal heart rate tracings develop, the insert can be immediately removed via its retrieval string, leading to rapid cessation of drug delivery.
  • Oxytocin Timing: Oxytocin may be initiated 30 to 60 minutes after removal of the Cervidil insert.
• Intracervical Gel (Prepidil): 0.5 mg dinoprostone in a 2.5-mL syringe administered through a catheter into the endocervical canal just below the internal os. May repeat every 6 hours to a maximum of 3 doses (1.5 mg) in 24 hours. Oxytocin must be delayed for 6 to 12 hours after the last gel dose. Prepidil cannot be easily retrieved if tachysystole occurs.
• Contraindications: Like misoprostol, dinoprostone is contraindicated in patients with a scarred uterus (prior cesarean or transmural uterine surgery). It is also contraindicated in patients with active asthma, unexplained vaginal bleeding, or multiparity (≥ 6 previous term births).

Clinical Comparison of Ripening Modalities

---